William R. Hunt

Emory University — United States

Medicine · Health Sciences

15h-index1.1kcitations154works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(45), Historical Economic and Social Studies(14), Neonatal Respiratory Health Research(11), Reformation and Early Modern Christianity(9), Child Nutrition and Feeding Issues(9)

Publications153 total

558 Dietary linoleic acid is associated with increased adiposity in adults with cystic fibrosis not taking CFTR modulators
Journal of Cystic Fibrosis·2025
697 Impact of abnormal glucose tolerance on plasma redox metabolites in cystic fibrosis
Journal of Cystic Fibrosis·2025
137 Effects of a specialist palliative care vs usual care among adults living with CF: a multisite randomized phase III clinical trial of the InSPIRe:CF intervention
Journal of Cystic Fibrosis·2025
455 Electronic medical record approach to enhance recruitment of individuals with cystic fibrosis for a dietary intervention trial
Journal of Cystic Fibrosis·2025
Relationship between skeletal muscle indicators and clinical outcomes in cystic fibrosis is modified by adiposity and CFTR modulator use: a cross-sectional analysis
American Journal of Clinical Nutrition·2025· 1 citedOpen Access
Vitamin D status in young adults with cystic fibrosis on highly effective CFTR modulator therapy
The Journal of Steroid Biochemistry and Molecular Biology·2025· 1 cited
Relationship Between Added Sugar Intake and Metabolic Outcomes in Adults With Cystic Fibrosis Using CFTR Modulator Therapy
Current Developments in Nutrition·2025Open Access
Not So “Sweet" Hydrothorax: A Classic Case of Pleuroperitoneal Fistula Complicating PD
American Journal of Respiratory and Critical Care Medicine·2025
Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocol
PLoS ONE·2025· 3 citedOpen Access
Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis: a protocol of a double-blind, randomised study
BMJ Open·2024Open Access
Perception and participation in sport and exercise in cystic fibrosis: The impact of CFTR modulators
Respiratory Medicine·2024· 2 cited
Hypogonadism in a Man With Cystic Fibrosis and an Unusually Low Serum Testosterone: A Cautionary Tale
AACE Clinical Case Reports·2024· 2 citedOpen Access
6500 Screening Rates in Emerging Adults With Cystic Fibrosis for Cystic Fibrosis-Related Bone Disease: A Retrospective Cohort Study
Journal of the Endocrine Society·2024Open Access
156 Effects of specialist palliative care consultation among adults cystic fibrosis: a multisite randomized phase III clinical trial of the InSPIRe:CF intervention
Journal of Cystic Fibrosis·2024
602 Clinical outcome indicators related to body composition in adults with cystic fibrosis
Journal of Cystic Fibrosis·2024
Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial
The Lancet Respiratory Medicine·2024· 18 cited
Impact of high-dose cholecalciferol (vitamin D3) and inulin prebiotic on intestinal and airway microbiota in adults with cystic fibrosis: A 2 × 2 randomized, placebo-controlled, double-blind pilot study
Journal of Clinical & Translational Endocrinology·2024· 3 citedOpen Access
Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFB): a clinical study protocol
2024· 2 citedOpen Access
Testosterone concentrations and associated predictors in men with cystic fibrosis: A retrospective, single-center study
The American Journal of the Medical Sciences·2024· 6 citedOpen Access
Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosis
Contemporary Clinical Trials Communications·2024· 3 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Vin Tangpricha(8), Jason M. Hansen(4), Malinda Wu(4), Michael Koval(3), Nael A. McCarty(3), Samuel A. Molina(3), Arlene A. Stecenko(3), Jessica A. Alvarez(3), Rachel W. Linnemann(3), Candela Manfredi(3), Eric J. Sorscher(3), Sarah E. Hempstead(2), Thomas R. Ziegler(2), Jane Lowers(2), Anne M. Fitzpatrick(2), Dio Kavalieratos(2), George M. Solomon(2), Rachel Rich(2), Ashleigh Streby(2), Brian Buehler(2)